Patent · US Active

Diagnosis and prognosis of breast cancer patients

US7863001B2 · kind B2 · utility

3Cited by
21References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 23, 2008
Grant dateJan 4, 2011
Priority date
Expiry dateJun 23, 2029

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A90/10
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to genetic markers whose expression is correlated with breast cancer. Specifically, the invention provides sets of markers whose expression patterns can be used to differentiate clinical conditions associated with breast cancer, such as the presence or absence of the estrogen receptor ESR1, and BRCA1 and sporadic tumors, and to provide information on the likelihood of tumor distant metastases within five years of initial diagnosis. The invention relates to methods of using these markers to distinguish these conditions. The invention also relates to kits containing ready-to-use microarrays and computer software for data analysis using the statistical methods disclosed herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.